Literature DB >> 10372431

Physiologic and biochemical monitoring during hyperbaric oxygenation: a review.

G G Rogatsky1, E G Shifrin, A Mayevsky.   

Abstract

Hyperbaric oxygenation (HBO2) is an important treatment given to various groups of patients exposed to pathologic situations (i.e., carbon monoxide exposure). Since many hyperbaric patients are critically ill and are being treated for life-threatening disorders, it is necessary to monitor various physiologic and biochemical parameters. This is a review of 193 publications covering a wide range of monitored parameters representing metabolic, hemodynamic, respiratory, electrical, and biochemical activities. The significance of monitoring the physiologic, medical, and specific oxygen toxicity effects during HBO2 exposure (MHBO2) is described and emphasized. Further development of new monitoring devices and technologies will enable the improvement of patient management during HBO2 treatment given under various medical conditions. This review also presents new ideas about possible future monitoring of brain function under HBO2 conditions in experimental animals as well as under clinical conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372431

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  4 in total

Review 1.  Shedding light on mitochondrial function by real time monitoring of NADH fluorescence: I. Basic methodology and animal studies.

Authors:  Avraham Mayevsky; Efrat Barbiro-Michaely
Journal:  J Clin Monit Comput       Date:  2012-12-01       Impact factor: 2.502

2.  Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures.

Authors:  Barbara Rinaldi; Salvatore Cuzzocrea; Maria Donniacuo; Annalisa Capuano; Donatella Di Palma; Francesco Imperatore; Emanuela Mazzon; Rosanna Di Paola; Loredana Sodano; Francesco Rossi
Journal:  Intensive Care Med       Date:  2011-05-13       Impact factor: 17.440

3.  Acute splenic irradiation reduces brain injury in the rat focal ischemic stroke model.

Authors:  Robert P Ostrowski; Reinhard W Schulte; Ying Nie; Ted Ling; Timothy Lee; Anatol Manaenko; Daila S Gridley; John H Zhang
Journal:  Transl Stroke Res       Date:  2012-12       Impact factor: 6.829

4.  Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome.

Authors:  Francesco Imperatore; Salvatore Cuzzocrea; Carlo Luongo; Giovanni Liguori; Antonella Scafuro; Antonella De Angelis; Francesco Rossi; Achille P Caputi; Amelia Filippelli
Journal:  Intensive Care Med       Date:  2004-02-12       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.